Martin Kang

Icahn School of Medicine at Mount Sinai

Papers

1

Total Citations

10

H-Index

1

About

Dr. Martin Kang is a leading surgical oncologist whose research focuses on the treatment and long-term outcomes of head and neck cancers, particularly human papillomavirus-positive oropharyngeal cancer (HPV+ OPC). His most cited work, a 2020 study on long-term outcomes after upfront transoral robotic surgery (TORS), provides critical insights into the clinical course of patients who experience recurrence following this minimally invasive approach. By characterizing disease failure patterns in HPV+ OPC, Dr. Kang’s research directly informs surgical decision-making and post-treatment surveillance strategies. This work, which has garnered significant attention in the field, highlights his commitment to improving survival and quality of life for patients with these increasingly prevalent cancers. Dr. Kang’s contributions are vital for clinicians navigating the complex landscape of HPV-related malignancies and optimizing robotic surgical outcomes.

Research Focus

Key Achievements

1
H-Index
1
Papers
10
Total Citations
10
Avg Citations/Paper
🏆 Most Cited Paper
Long‐term outcomes in patients with recurrent human papillomavirus‐positive oropharyngeal cancer after upfront transoral robotic surgery
10 citations · 2020
📈 Most Prolific Year: 2020 (1 Papers)
🤝 Key Collaborators: 11
🏛 Institutions: Icahn School of Medicine at Mount Sinai

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago